Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic-associated diarrhea: A double-blind, randomized controlled trial

Clin Transl Med. 2023 Apr;13(4):e1184. doi: 10.1002/ctm2.1184.
No abstract available

Keywords: antibiotics-associated diarrhea; children; double-blind randomized controlled trial; gut microbiome; probiotics.

Publication types

  • Randomized Controlled Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacillus licheniformis*
  • Diarrhea / drug therapy
  • Diarrhea / prevention & control
  • Gastrointestinal Microbiome*
  • Humans
  • Probiotics*

Substances

  • Anti-Bacterial Agents